BERLIN (Reuters) – The European Medicines Agency (EMA) is expected to approve the COVID-19 vaccine developed by AstraZeneca and Oxford University on Friday, a spokesman of German’s health ministry said.
EU officials are due to seek clarification from AstraZeneca executives on unexpected delivery problems on Monday afternoon.
(Reporting by Kirsti Knolle, editing by Thomas Escritt)
